BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36759279)

  • 1. Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis.
    Zheng Z; Mukhametova L; Boffa MB; Moore EE; Wolberg AS; Urano T; Kim PY
    J Thromb Haemost; 2023 Apr; 21(4):1043-1054. PubMed ID: 36759279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasminogen activation and regulation of fibrinolysis].
    Madoiwa S
    Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intersection of Coagulation and Fibrinolysis by the Glycosylphosphatidylinositol (GPI)-Anchored Serine Protease Testisin.
    Buzza MS; Pawar NR; Strong AA; Antalis TM
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis at the fluid-solid interface of thrombi.
    Kolev K; Longstaff C; Machovich R
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Oct; 3(4):341-55. PubMed ID: 16250865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma.
    Cruz DBD; Helms J; Aquino LR; Stiel L; Cougourdan L; Broussard C; Chafey P; Riès-Kautt M; Meziani F; Toti F; Gaussem P; Anglés-Cano E
    FASEB J; 2019 Dec; 33(12):14270-14280. PubMed ID: 31682515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
    Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.
    Schneider M; Nesheim M
    J Biol Chem; 2004 Apr; 279(14):13333-9. PubMed ID: 14715655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct delivery of plasmin using clot-anchoring thrombin-responsive nanoparticles for targeted fibrinolytic therapy.
    Sun M; Hao Pontius MH; Yang S; Pendekanti T; Raghunathan S; Shavit JA; Sen Gupta A
    J Thromb Haemost; 2023 Apr; 21(4):983-994. PubMed ID: 36696210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.
    Carr ME; Alving BM
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):567-73. PubMed ID: 7578900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of activated coagulation factor XII in overall clot stability and fibrinolysis.
    Konings J; Hoving LR; Ariëns RS; Hethershaw EL; Ninivaggi M; Hardy LJ; de Laat B; Ten Cate H; Philippou H; Govers-Riemslag JW
    Thromb Res; 2015 Aug; 136(2):474-80. PubMed ID: 26153047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fibrinolytic system in man.
    Collen D; Lijnen HR
    Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin.
    Mutch NJ; Engel R; Uitte de Willige S; Philippou H; Ariëns RA
    Blood; 2010 May; 115(19):3980-8. PubMed ID: 20228273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fibrinolysis renaissance.
    Mutch NJ; Medcalf RL
    J Thromb Haemost; 2023 Dec; 21(12):3304-3316. PubMed ID: 38000850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly potent fibrinolytic serine protease from Streptomyces.
    Uesugi Y; Usuki H; Iwabuchi M; Hatanaka T
    Enzyme Microb Technol; 2011 Jan; 48(1):7-12. PubMed ID: 22112764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
    Urano S; Metzger AR; Castellino FJ
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin.
    Sakharov DV; Lijnen HR; Rijken DC
    J Biol Chem; 1996 Nov; 271(44):27912-8. PubMed ID: 8910391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolysis: the key to new pathogenetic mechanisms.
    Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
    Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
    Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
    Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
    Sakai M; Watanuki M; Matsuo O
    Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.